Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361944438> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W4361944438 abstract "<div>Abstract<p><b>Purpose:</b> The multikinase inhibitor sorafenib displays antitumor activity in preclinical models of osteosarcoma. However, in sorafenib-treated patients with metastatic-relapsed osteosarcoma, disease stabilization and tumor shrinkage were short-lived and drug resistance occurred. We explored the sorafenib treatment escape mechanisms to overcome their drawbacks.</p><p><b>Experimental Design:</b> Immunoprecipitation, Western blotting, and immunohistochemistry were used to analyze the mTOR pathway [mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2)]. Cell viability, colony growth, and cell migration were evaluated in different osteosarcoma cell lines (MNNG-HOS, HOS, KHOS/NP, MG63, U-2OS, SJSA-1, and SAOS-2) after scalar dose treatment with sorafenib (10–0.625 μmol/L), rapamycin-analog everolimus (100–6.25 nmol/L), and combinations of the two. Cell cycle, reactive oxygen species (ROS) production, and apoptosis were assessed by flow cytometry. Nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice injected with MNNG-HOS cells were used to determine antitumor and antimetastatic effects. Angiogenesis and vascularization were evaluated <i>in vitro</i> by exploiting endothelial branching morphogenesis assays and <i>in vivo</i> in xenografted mice and chorioallantoic membranes.</p><p><b>Results:</b> After sorafenib treatment, mTORC1 signaling was reduced (downstream target P-S6), whereas mTORC2 was increased (phospho-mTOR Ser2481) in MNNG-HOS xenografts compared with vehicle-treated mice. Combining sorafenib with everolimus resulted in complete abrogation of both mTORC1 [through ROS-mediated AMP-activated kinase (AMPK) activation] and mTORC2 (through complex disassembly). The sorafenib/everolimus combination yielded: (i) enhanced antiproliferative and proapoptotic effects, (ii) impaired tumor growth, (iii) potentiated antiangiogenesis, and (iv) reduced migratory and metastatic potential.</p><p><b>Conclusion:</b> mTORC2 activation is an escape mechanism from sorafenib treatment. When sorafenib is combined with everolimus, its antitumor activity is increased by complete inhibition of the mTOR pathway in the preclinical setting. <i>Clin Cancer Res; 19(8); 2117–31. ©2013 AACR</i>.</p></div>" @default.
- W4361944438 created "2023-04-05" @default.
- W4361944438 creator A5009087591 @default.
- W4361944438 creator A5019347333 @default.
- W4361944438 creator A5027747604 @default.
- W4361944438 creator A5041240875 @default.
- W4361944438 creator A5049670577 @default.
- W4361944438 creator A5050031420 @default.
- W4361944438 creator A5050932223 @default.
- W4361944438 creator A5052085580 @default.
- W4361944438 creator A5052120219 @default.
- W4361944438 creator A5054601656 @default.
- W4361944438 creator A5056702454 @default.
- W4361944438 creator A5068651198 @default.
- W4361944438 creator A5073707704 @default.
- W4361944438 creator A5079227239 @default.
- W4361944438 creator A5083948167 @default.
- W4361944438 creator A5086215437 @default.
- W4361944438 creator A5086229991 @default.
- W4361944438 date "2023-03-31" @default.
- W4361944438 modified "2023-10-14" @default.
- W4361944438 title "Data from The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 Upregulation in Osteosarcoma Preclinical Models" @default.
- W4361944438 doi "https://doi.org/10.1158/1078-0432.c.6521967" @default.
- W4361944438 hasPublicationYear "2023" @default.
- W4361944438 type Work @default.
- W4361944438 citedByCount "0" @default.
- W4361944438 crossrefType "posted-content" @default.
- W4361944438 hasAuthorship W4361944438A5009087591 @default.
- W4361944438 hasAuthorship W4361944438A5019347333 @default.
- W4361944438 hasAuthorship W4361944438A5027747604 @default.
- W4361944438 hasAuthorship W4361944438A5041240875 @default.
- W4361944438 hasAuthorship W4361944438A5049670577 @default.
- W4361944438 hasAuthorship W4361944438A5050031420 @default.
- W4361944438 hasAuthorship W4361944438A5050932223 @default.
- W4361944438 hasAuthorship W4361944438A5052085580 @default.
- W4361944438 hasAuthorship W4361944438A5052120219 @default.
- W4361944438 hasAuthorship W4361944438A5054601656 @default.
- W4361944438 hasAuthorship W4361944438A5056702454 @default.
- W4361944438 hasAuthorship W4361944438A5068651198 @default.
- W4361944438 hasAuthorship W4361944438A5073707704 @default.
- W4361944438 hasAuthorship W4361944438A5079227239 @default.
- W4361944438 hasAuthorship W4361944438A5083948167 @default.
- W4361944438 hasAuthorship W4361944438A5086215437 @default.
- W4361944438 hasAuthorship W4361944438A5086229991 @default.
- W4361944438 hasBestOaLocation W43619444382 @default.
- W4361944438 hasConcept C107846503 @default.
- W4361944438 hasConcept C126322002 @default.
- W4361944438 hasConcept C185592680 @default.
- W4361944438 hasConcept C190283241 @default.
- W4361944438 hasConcept C2778019345 @default.
- W4361944438 hasConcept C2778695046 @default.
- W4361944438 hasConcept C2779699572 @default.
- W4361944438 hasConcept C2780394083 @default.
- W4361944438 hasConcept C502942594 @default.
- W4361944438 hasConcept C55493867 @default.
- W4361944438 hasConcept C71924100 @default.
- W4361944438 hasConcept C86554907 @default.
- W4361944438 hasConcept C98490376 @default.
- W4361944438 hasConceptScore W4361944438C107846503 @default.
- W4361944438 hasConceptScore W4361944438C126322002 @default.
- W4361944438 hasConceptScore W4361944438C185592680 @default.
- W4361944438 hasConceptScore W4361944438C190283241 @default.
- W4361944438 hasConceptScore W4361944438C2778019345 @default.
- W4361944438 hasConceptScore W4361944438C2778695046 @default.
- W4361944438 hasConceptScore W4361944438C2779699572 @default.
- W4361944438 hasConceptScore W4361944438C2780394083 @default.
- W4361944438 hasConceptScore W4361944438C502942594 @default.
- W4361944438 hasConceptScore W4361944438C55493867 @default.
- W4361944438 hasConceptScore W4361944438C71924100 @default.
- W4361944438 hasConceptScore W4361944438C86554907 @default.
- W4361944438 hasConceptScore W4361944438C98490376 @default.
- W4361944438 hasLocation W43619444381 @default.
- W4361944438 hasLocation W43619444382 @default.
- W4361944438 hasOpenAccess W4361944438 @default.
- W4361944438 hasPrimaryLocation W43619444381 @default.
- W4361944438 hasRelatedWork W1566387143 @default.
- W4361944438 hasRelatedWork W2058681119 @default.
- W4361944438 hasRelatedWork W2089582883 @default.
- W4361944438 hasRelatedWork W2101083009 @default.
- W4361944438 hasRelatedWork W2115508086 @default.
- W4361944438 hasRelatedWork W2330924021 @default.
- W4361944438 hasRelatedWork W2406111920 @default.
- W4361944438 hasRelatedWork W2475132403 @default.
- W4361944438 hasRelatedWork W2624197544 @default.
- W4361944438 hasRelatedWork W2772286407 @default.
- W4361944438 isParatext "false" @default.
- W4361944438 isRetracted "false" @default.
- W4361944438 workType "article" @default.